Home » Topics » Regulatory

Regulatory
RSS

ODAC meeting rescheduled for early December

Oct. 17, 2001

FDA issues approvable letter for UroXatral

Oct. 15, 2001

Novel combinations claimed by Merck Frosst for depression and anxiety

Oct. 11, 2001

Clinically used pain medication now claimed for IBS

Oct. 11, 2001

Biovail files NDA for FlashDose version of fluoxetine

Oct. 5, 2001

FDA approves Entocort EC for treatment of Crohn's disease

Oct. 5, 2001

Phase II trial to compare two ciprofloxacin formulations for urinary tract infections

Oct. 4, 2001

Atrix submits NDA for Leuprogel Three-Month Depot for prostate cancer

Sep. 28, 2001

sBLA submitted for ARANESP

Sep. 25, 2001

New strength of Zomig-ZMT approved by FDA

Sep. 21, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...